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1. Introduction 
More than 220,000 patients are admitted to hospital each year with acute pancreatitis in the 
United States alone.1 The most common etiology of acute pancreatitis is gallstones. This 
chapter will focus on diagnostic and management issues related to acute biliary pancreatitis 
(ABP). Differentiating gallstone-induced acute pancreatitis from other etiologies (alcohol, 
medication induced, hypertriglyceridemia) should be prioritized in the initial investigation 
of acute pancreatitis as ABP has its own specific management considerations. 
2. Epidemiology 
Cholelithiasis, or gallstones, are present in up to 10% of the general population. Risk factors 
for developing gallstones include female sex, advancing age, ethnicity and genetics, obesity 
and the metabolic syndrome, rapid weight loss, high fat low fiber diet, pregnancy, and 
certain disease states such as cirrhosis and Crohn’s disease.2 Gallstones are present in 35-
75% of all patients with acute pancreatitis in developed nations.3,4 Up to 8% of patients with 
symptomatic gallstones will develop biliary pancreatitis due to migration into the bile duct, 
and ABP may be the initial presentation of gallstones in up to 40% of previously 
asymptomatic patients.5 The yearly incidence of ABP is estimated at 4.9-80.0 cases per 
100,000 population in the United States. Although most cases of ABP are mild and self-
limited, case fatality rates as high as 15% have been reported in severe cases.6 Risk factors 
for ABP include female gender with a ratio of 2:1 over males, age, with an incidence of ABP 
                                                 
1 Whitcomb DC. Clinical practice. Acute pancreatitis. NEJM. 2006;354:2142-2150. 
2 Shaffer SA. Epidemiology of gallbladder stone disease. Best Practice and Research Clinical 
Gastroenterology 2006;20:981-996. 
3 van Geenen EJM, van der Preet DL, Bhagirath R, et al. Etiology and diagnosis of acute biliary 
pancreatitis. Gastroenterology & Hepatology. 2010;7:495-502.  
4 Agrawal S, Jonnalagadda S. Gallstones, from gallbladder to gut. Management options for diverse 
complications. Postgraduate Medicine. 2000;108:143-153. 
5 van Erpecum KJ. Complications of bile-duct stones: acute cholangitis and pancreatitis. Best Practice & 
Research Clinical Gastroenterology. 2006;20:1139-1152.  
6 Kaw M, Al-Antably Y, Kaw P. Management of of gallstone pancreatitis: cholecystectomy or ERCP and 
endoscopic sphincterotomy. Gastrointestinal Endoscopy.2002;56:61-65. 
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over 3 times higher at age 75 compared with age 20, and ethnicity, with increased incidence 
in those of white and Hispanic backgrounds.7 
3. Pathogenesis 
The exact pathogenesis of acute biliary pancreatitis is unclear. Several structural and genetic 
explanations are supported in the current literature.  
3.1 Structural 
One mechanism involves obstruction of the common bile and pancreatic ducts as gallstones 
migrate down and become impacted in the ampulla of Vater. Classic observational studies 
revealed gallstones may be retrieved from the stool of patients with biliary pancreatitis in 
>90% of cases as compared to approximately 10% of patients with symptomatic gallstones in 
the absence of pancreatitis, and in no patients with alcohol induced pancreatitis.8,9 The 
precise mechanism of how the gallstones passing through the ampulla initiate and sustain 
pancreatic inflammation is unknown. It seems just the passage of material through the 
ampulla of Vater without overt obstruction may be enough to initiate pancreatitis as in the 
case of sludge containing microlithiasis. In this situation, passage of material through the 
ampulla may lead to spasm or local edema of the sphincter of Oddi resulting in temporary 
obstruction. Episodes of recurrent acute pancreatitis caused by microlithiasis may be 
significantly reduced by cholecystectomy or endoscopic sphincterotomy (ES). 
A second mechanism involves reflux of infected bile into the pancreatic duct. The 
inflammation associated with cholangitis may extend as far as the pancreas initiating the 
episode of acute pancreatitis. Normal pressures in the pancreatic duct are well above 
pressures in the common bile duct (CBD), preventing reflux of bile into the pancreatic duct 
under physiologic conditions. With ampullary obstruction secondary to passing gallstones, 
pressure gradients may shift, allowing flow of bile and pancreatic juice back into the 
pancreatic duct. Studies have shown sterile refluxate does not cause acute pancreatitis, 
however infected bile (especially with Escherichia coli) or mixtures of bile and pancreatic 
juice can lead to acute pancreatitis.10 
Gallstone-related factors have also been implicated as they relate to the number and 
frequency of gallstones that pass into the common bile duct and through the ampulla of 
Vater as well as the likelihood of obstruction. These factors include small size (<2-5mm), 
higher number (>20) of gallstones in the gallbladder, irregular surface of the gallstones, 
good emptying of the gallbladder with meals, and cystic duct width over 5mm. Next, bile 
duct anatomy including an enlarged CBD (>1.3mm), a wide angle between the CBD and 
pancreatic duct, and a common pancreaticobiliary channel may also predispose to acute 
                                                 
7 van Geenen EJM, van der Preet DL, Bhagirath R, et al. Etiology and diagnosis of acute biliary 
pancreatitis. Gastroenterology & Hepatology. 2010;7:495-502. 
8 Acosta JM, Ledesma CL. Gallstone migration as a cause of acute pancreatitis. NEJM. 1974;290:484-487. 
9 Acosta JM, Rossi R, Ledesma CL. The usefulness of stool screening for diagnosing cholelithiasis in 
acute pancreatitis. A description of the technique. American Journal of Digestive Diseases. 1977;22:168-172. 
10 van Geenen EJM, van der Preet DL, Bhagirath R, et al. Etiology and diagnosis of acute biliary 
pancreatitis. Gastroenterology & Hepatology. 2010;7:495-502. 
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biliary pancreatitis. Patients with a history of ABP were found to be twice as likely to have a 
common pancreaticobiliary channel when compared to those with choledocholithiasis and 
cholelithiasis without a history of pancreatitis.11 
3.2 Genetic 
Genetic variations and mutations have been well described in idiopathic pancreatitis, and it 
appears that genetics may play a role in selected circumstances of biliary pancreatitis as 
well. Marschall et al. recently published a review of the genetic basis for gallstone formation 
and symptomatic gallstone disease including the development of biliary pancreatitis.12 
Using data from 43,141 mono- and dizygotic twins born between 1900 and 1958, they 
calculated that genetics account for up to 25% of the phenotypic variation among twins. As 
cholesterol stones account for over 90% of all gallstones, metabolic pathways involved in the 
formation of cholesterol stones have been studied. Bile is made up of water and three lipid 
components, namely cholesterol (4%), phospholipids (24%), and bile salts (72%). Genes 
encoding for transport proteins have been identified for each of these components with 
varying significance for the risk of ABP.  
One such susceptibility locus is the D19H variant of ABCG8, a cholesterol transport protein. 
This allele increases the ABCG5/8 mediated transfer of cholesterol into bile, resulting in 
biliary cholesterol hypersaturation, a necessary pre-requisite for cholesterol stones. 
Marschall et al. determined an odds ratio of 2.5 (95% CI 1.3-4.8) for the formation of 
symptomatic gallstones disease in 341 Swedish twins with at least one D19H allele.  
Cases of recurrent ABP have been associated with a mutation in the ABCB4 gene, which 
encodes for multidrug resistant p-glycoprotein MDR3, a protein involved translocation of 
phospholipids from the inner to the outer leaflet of the canalicular membrane of 
hepatocytes. Point mutations in ABCB4 have been associated with low phospholipid-
associated cholelithiasis syndrome, which is characterized by early gallstone disease (<40 
years old), intrahepatic sludge and microlithiasis, and recurrent biliary disease after 
cholecystectomy. Mutations in ABCB4 have also been associated with several other 
hepatobiliary diseases including intrahepatic cholestasis of pregnancy, progressive familial 
intrahepatic cholestasis type 3, and adult biliary cirrhosis.13,14 
Bile salts are the third lipid component with several susceptibility loci identified. The 
ABCB11 gene, encoding the bile salt export pump (BSEP), has been found as a rare cause of 
cholesterol stones with less than 2% of young adults being heterozygous for functionally 
relevant mutations. Expression of ABC transporters ABCB11 and ABCB4 are induced by the 
farnesoid X receptor (FXR), a bile acid sensor that regulates hepatic bile acid synthesis, 
uptake, and excretion genes, as well as other genes involved with turnover of cholesterol 
                                                 
11 van Geenen EJM, van der Preet DL, Bhagirath R, et al. Etiology and diagnosis of acute biliary 
pancreatitis. Gastroenterology & Hepatology. 2010;7:495-502. 
12 Marschall HU, Katsika D, Rudling M, Einarsson C. The genetic background of gallstone formation: an 
update. Biochemical and Biophysical Research Communications. 2010;396:58-62. 
13 van Geenen EJM, van der Preet DL, Bhagirath R, et al. Etiology and diagnosis of acute biliary 
pancreatitis. Gastroenterology & Hepatology. 2010;7:495-502. 
14 Marschall HU, Katsika D, Rudling M, Einarsson C. The genetic background of gallstone formation: an 
update. Biochemical and Biophysical Research Communications. 2010;396:58-62. 
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and glucose homeostasis. The reduction in bile acid synthesis that results is associated with 
increased cholesterol gallstone formation. The A105G variant of the SLC10A2 gene, 
encoding the apical sodium-dependent bile acid transporter (ASBT) was also identified as a 
risk factor for cholesterol stones with an odds ratio of 2.04 (95% CI 1.19-3.55).15 
4. Diagnosis 
The presentation of acute pancreatitis may be quite similar whether the etiologic basis is 
biliary or non-biliary in origin. This makes distinguishing acute biliary pancreatitis from 
other etiologies somewhat challenging. Certain clues may exist on history and physical 
examination, however laboratory investigations and abdominal imaging are often required 
for a more definitive diagnosis.  
4.1 Clinical presentation 
Abdominal pain, classically severe epigastric pain radiating to the back that is worse in the 
supine position, is a hallmark of acute pancreatitis of any etiology. The abdominal pain may 
worsen over the course of several hours and may be associated with nausea and vomiting. 
Patients may also report worsening of their pain following meals. Due to the significant 
inflammatory process and release of cytokines, fever is another common manifestation. Still, 
most patients will have a mild, self-limited course of their biliary pancreatitis. In one early 
series of 153 patients with ABP, only twenty-two (14%) were febrile and thirty (20%) were 
volume depleted. Eighty-one (53%) had right upper quadrant tenderness, and seventy-one 
(46%) had mid-epigastric tenderness. Notably, twenty-one (14%) had completely benign 
abdominal examinations, and only nine patients (6%) had diffuse peritonitis.16 
During an episode of acute pancreatitis, pancreatic enzymes, vasoactive materials such as 
kinins, and other toxic substances extravasate from the pancreas into surrounding areas 
resulting in chemical irritation and contribute to third space losses that may lead to 
hypovolemia, tachycardia, and hypotension. In this situation, the abdomen may also 
become distended and tympanic due to paralytic ileus. When toxic mediators reach the 
systemic circulation, the corresponding systemic inflammatory response syndrome (SIRS) 
may be severe and result in end-organ damage including acute respiratory distress 
syndrome (ARDS) and acute kidney injury. Hemorrhagic pancreatitis may lead to the classic 
Cullen’s sign, with ecchymosis in the periumbilical region, and Grey Turner’s sign, with 
ecchymosis of the flank.  
History of known gallstones, especially symptomatic gallstone disease such as biliary colic 
may indicate a biliary etiology, although it cannot rule out other etiologies of acute 
pancreatitis, nor can the absence of gallstones rule out a biliary source, as pancreatitis can be 
the first presentation of gallstone disease, and sludge and microcalculi are still a possibility. 
The absence of other associated etiologies including significant alcohol intake, initiation of 
medications known to be associated with pancreatitis, recent endoscopic retrograde 
cholangiopancreatography (ERCP), and known hypertriglyceridemia or hypercalcemia may 
                                                 
15 Marschall HU, Katsika D, Rudling M, Einarsson C. The genetic background of gallstone formation: an 
update. Biochemical and Biophysical Research Communications. 2010;396:58-62. 
16
 Frel G, Frel V, Thirlby R, McClelland R. Biliary pancreatitis: clinical presentation and surgical 
management. American Journal of Surgery 1986;151:170-175. 
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also lead to the diagnosis of ABP. Scleral icterus or overt jaundice may be associated with 
acute pancreatitis in select cases due to edema of the head of the pancreas or an obstructing 
stone in the case of biliary pancreatitis. History and physical examination should also aim to 
rule out mimickers of pancreatitis including acute cholecystitis, perforated duodenal ulcer, 
intestinal obstruction, mesenteric ischemia, or ruptured aneurysm amongst other etiologies.  
4.2 Biochemistry 
The diagnosis of pancreatitis of any etiology is classically made with elevations in serum 
amylase and lipase. Enzyme levels tend to rise within 4 - 8 hours of onset, peak around 24 
hours, and return to normal between 2 - 14 days after onset of acute pancreatitis. Lipase has 
a longer half-life, up to 12 hours, compared to a half-life of only 2 hours for serum amylase, 
and thus lasts several days longer in the bloodstream. Most would consider elevations in 
amylase and lipase upwards of three times the upper limit of normal significant in the 
diagnosis of acute pancreatitis. However, in one retrospective study of 284 patients with a 
first episode of acute pancreatitis, over 30% of patients had amylase levels below three times 
the upper limits of normal and 18% had lipase levels below three times the upper limit of 
normal.17 They did show that patients with a biliary origin of their acute pancreatitis were 
significantly (p = 0.007) more likely to have elevations in serum amylase over three times the 
normal limit compared to non-biliary etiologies. This study also determined that there was 
no association between level of elevation of enzymes and severity of disease looking at 
factors such as development of pseudocysts, renal impairment and need for dialysis, ICU 
admission requiring ventilatory support, need for surgery, and overall mortality.18  
It is important, however, to remember that a long differential diagnosis exists for elevations in 
serum amylase and lipase. Other pancreatic diseases, acute cholecystitis or cholangitis, post-
ERCP, trauma, bowel obstruction or ischemia, and medications may lead to elevations in both 
serum amylase and lipase. Additionally, renal impairment, penetrating peptic ulcer disease, 
salivary disease, several solid tumors and multiple myeloma, and gynecologic disease can 
raise serum amylase but not serum lipase, making lipase a more specific serum marker.  
With a diagnosis of acute pancreatitis made, biliary etiology may be determined using 
several serum markers, especially serum alanine aminotransferase (ALT). As with serum 
amylase and lipase, elevations over three times the upper limit of normal are considered 
significant, however, up to 15% of patients with biliary pancreatitis will have normal liver 
enzymes.19 There is also a differential diagnosis for elevations in ALT, most significantly 
alcohol (the second leading cause of acute pancreatitis in Western countries), viral hepatitis, 
and non-alcoholic fatty liver disease. 
There have been several studies looking at the diagnosis of biliary pancreatitis through the 
use of ALT, either alone or in combination with other serum markers. Early studies looked 
                                                 
17 Lankisch PG, Burchard-Reckert S, Lehnick D. Underestimation of acute pancreatitis: patients with 
only a small increase in amylase/lipase levels can also have or develop severe acute pancreatitis. Gut. 
1999;44:542-544. 
18 Lankisch PG, Burchard-Reckert S, Lehnick D. Underestimation of acute pancreatitis: patients with 
only a small increase in amylase/lipase levels can also have or develop severe acute pancreatitis. Gut. 
1999;44:542-544. 
19 van Geenen EJM, van der Preet DL, Bhagirath R, et al. Etiology and diagnosis of acute biliary 
pancreatitis. Gastroenterology & Hepatology. 2010;7:495-502. 
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at using multiple serum and urine biomarkers and occasionally clinical data to distinguish 
biliary from non-biliary etiologies. One such study developed a scoring system using seven 
variables including serum and urine amylase, serum AST and ALT, ALP, lipase/amylase 
ratio, and erythrocyte mean corpuscular volume (MCV) to differentiate biliary from 
alcoholic pancreatitis.20 Each parameter was given a single point, and a score of 4 or greater 
out of 7 was significantly correlated to a biliary etiology of pancreatitis (p < 0.0001), and a 
score below 4/7 correlated with alcoholic etiology with a sensitivity of 92% and specificity 
of 94%. On the other hand, Davidson et al. argued against multi-factor systems in their 
study that compared test characteristics of a one-, three-, and five-factor test for biliary 
pancreatitis.21 The one-factor test used serum ALT and aspartate aminotransferase (AST) 
alone, the three-factor test used alkaline phosphatase (ALP) and bilirubin in addition to 
transaminases, and the five-factor test included clinical data such as age and female sex, as 
well as amylase, alkaline phosphatase, and transaminases. In their study, the one- and three-
factor tests performed slightly better than the five-factor test, and thus using serum 
transaminases alone were recommended for simplicity.  
More recent studies have lent support for single-factor systems. One study looked at serum 
ALT ≥ 80 (U/L) in a cohort of 68 patients with acute pancreatitis, of which 44 (65%) had a 
biliary etiology.22 They demonstrated that serum ALT ≥ 80 (two times the upper limit of 
normal) had a sensitivity of 91%, specificity of 100%, positive predictive value (PPV) of 
100% and negative predictive value (NPV) of 86%. Combined with abdominal ultrasound, 
test characteristics improved somewhat with a sensitivity of 98%, specificity of 100%, PPV of 
100% and NPV of 96%. A subsequent study looked at a cohort of 213 patients, of which 62% 
had ABP confirmed with endoscopic ultrasound (EUS), and found serum ALT levels over 
two times the upper limit of normal had a sensitivity of 74%, specificity of 84%, PPV of 88%, 
and NPV of 66% for predicting a biliary etiology, whereas serum ALT levels over three 
times the upper limit of normal had a sensitivity of 61%, specificity of 91%, PPV of 92%, and 
NPV of 59%.  
4.3 Abdominal imaging 
The contribution of medical imaging to the diagnosis and evaluation of pancreatitis has 
evolved substantially. Early plain film description of the effects of pancreatic inflammation 
on the intra-abdominal bowel gas pattern has emerged over 50 years ago. Despite today’s 
widespread use of modern imaging technology including MRCP, these alterations in bowel 
gas patterns remain an occasional useful adjunct in the diagnosis of pancreatitis.  
Various abdominal film patterns have been described and may be occasionally seen in the 
setting of pancreatitis. One of the better described is the “colon cutoff sign”. In this pattern a 
dilated transverse colon appears to be abruptly cutoff occasionally simulating the 
appearance of colonic obstruction. This pattern is likely related to inflammation of the 
phrenicocolic ligament causing spasm or occasionally actual mechanical narrowing in the 
                                                 
20 Stimac D, Lenac T, Marusic Z. A scoring system for early differentiation of the etiology of acute 
pancreatitis. Scandinavian Journal of Gastroenterology 1998;33:209-211. 
21 Davidson BR, Neoptolemos JP, Leese T, Carr-Locke DL. Biochemical prediction of gallstones in acute 
pancreatitis: a prospective study of three systems. British Journal of Surgery 1988;75:213-215. 
22 Ammori BJ, Boreham B, Lewis P, Roberts SA. The biochemical detection of biliary etiology of acute 
pancreatitis on admission: a revisit in the modern era of biliary imaging. Pancreas 2003;26(2):e32-e35. 
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region of the splenic flexure. This appearance is further accentuated on the background of 
an adynamic colon. Additional imaging findings may include a mottled appearance of the 
peripancreatic region secondary to fat necrosis or peripancreatic gas in the setting of 
suppurative pancreatitis. Numerous other non-specific signs in the setting of pancreatitis 
have been described including ascites, left sided pleural effusion and diaphragmatic 
elevation. Needless to say all these signs require additional imaging modalities, clinical and 
biochemical correlation for to establish the diagnosis. 
4.3.1 Ultrasonography 
Despite its dependence on operator skill and patient’s body habitus ultrasonography has 
become a mainstay in the imaging of suspected biliary pancreatitis. In the setting of acute 
inflammation the pancreas may appear focally or diffusely enlarged, as well as relatively 
hypoechoic secondary to parenchymal edema. This is a reversal of the normal pattern in 
which the pancreas is echogenic relative to the adjacent liver. The main utility of 
sonography however is in its ability to image the biliary system in the search for 
cholelithiasis/choledocholithiasis as the etiology in order to guide further management. The 
widespread availability, sensitivity and relatively low cost of ultrasonography makes it 
particularly suitable for this role. Biliary stones typically appear as echogenic foci with 
posterior clean shadowing (Figure 1). Small stones and sludge however may not  
demonstrate posterior shadowing. Stones are more easily appreciated in the setting of 
biliary dilatation although distal CBD stones may remain obscured by overlying bowel gas. 
 
Fig. 1. Sonographic image demonstrating the typical appearance of CBD stones. Three 
stones (arrows) are visualized within a mildly dilated distal CBD. The stones appear as 
echogenic foci with posterior shadowing (best appreciated in the most proximal stone). 
Layering sludge and stones (asterisks) are also appreciated within the gallbladder (GB). 
www.intechopen.com
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4.3.2 Computed tomography  
Computed tomography (CT) has unique advantages in the evaluation of pancreatitis. It is 
relatively cheaper, non-invasive and more available as compared to ERCP and its sensitivity 
does not depend on the sonographer or the patient’s body habitus as is the case with 
ultrasound. An inflamed pancreas may appear enlarged and heterogeneous with 
surrounding inflammatory changes. CT is also particularly useful is the evaluation of 
pancreatic necrosis, pseudocyst formation or other secondary complications of pancreatitis.  
In the evaluation of a biliary cause of pancreatitis, CT however does have a significant 
weakness as up to 25% of biliary stones may be isodense to bile and therefore poorly 
visualized. Visible CBD stones may appear as a dense intraluminal mass with the so called 
“target sign” (Figure 2). As with other modalities, CBD dilatation may signal an underlying 
obstructing stone or mass and may require further evaluation with other methods in order 
to elucidate the underlying cause.  
 
Fig. 2. Coronal reformatted CT centered on the distal CBD. Two dense stones(arrows) are 
noted in the distal CBD. The CBD is dilated secondary to the obstructing stones.  
www.intechopen.com
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4.3.3 Magnetic resonance cholangiopancreatography 
Magnetic resonance cholangiopancreatography (MRCP) is the most sensitive and specific 
non-invasive method of assessing the biliary system for choledocholithiasis as an 
underlying etiology for pancreatitis. MRCP uses a heavily T2 weighted sequence which 
highlights the biliary ducts due to their high water content. The signal of the surrounding 
soft tissues saturates out, thus allowing for exquisite visualization of the bright bile ducts in 
the background of low intensity surrounding soft tissues (Figure 3). In this setting biliary 
duct stones appear as dark signal voids within the bright bile fluid (Figure 4).  
MRCP is comparable to ERCP with respect to its sensitivity in the detection of 
choledocholithiasis (Table 1). Although MRCP has lower special resolution as compared to 
ERCP and therapeutic interventions cannot be performed, it does afford several advantages. 
MRCP is non-invasive, it is less operator dependent, does not use ionizing radiation, and 
allows for visualization of the surrounding tissues when combined with additional MR 
sequences. Major disadvantages of MRCP include increased cost, decreased availability in 
many centers, and it requires a compliant patient to lie still and flat for 30-60 minutes, which 
may be difficult in the setting of acute pancreatitis when patients are in a significant amount 
of pain that may be worsened by a supine position. 
 
Fig. 3. Axial T2 image obtained as a part of the MRCP study demonstrating a stone at the 
distal CBD (arrow). The insertion point of the pancreatic duct into the distal CBD near the 
ampulla is also well visualized (double arrows). Courtesy of Dr. Y. Krakowsky. 
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Fig. 4. Coronal MRCP image in the same patient at Figure 2. Image demonstrates two signal 
voids (arrows) on the background of the high intensity bile in the dilated CBD. The high 
water content intraluminal fluid in the duodenum (D) is also well appreciated.  
4.3.4 Endoscopic retrograde cholangiopancreatography  
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a highly sensitive and specific 
test for assessing the biliary tree and in particular looking for choledocholithiasis (Table 1). 
Using a side-viewing endoscope, the ampulla is identified and cannulated, after which dye 
is injected into the biliary tree. Stones in the common bile duct show up as a filling defect on 
fluoroscopic imaging (Figure 5). During ERCP, endoscopic sphincterotomy (ES) may be 
performed to allow for improved passage of sludge and stones into the duodenum. 
ERCP is the only imaging modality that can also be used therapeutically for removing CBD 
stones and sludge from the common bile duct. However, the major disadvantage to using 
ERCP for the initial diagnosis of a biliary etiology of pancreatitis is the potential for 
exacerbating the acute episode of pancreatitis, and therefore this modality should only be 
used in conjunction with endoscopic sphincterotomy for treatment of impacted stones in 
jaundiced patients, those with signs and symptoms of biliary sepsis or potentially in severe 
ABP. 
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Fig. 5. Fluoroscopic image demonstrating a dilated common bile duct and several common 
bile duct stones seen as filling defects (arrows) at the time of ERCP. 
4.3.5 Endoscopic ultrasound 
Endoscopic ultrasound (EUS) has the highest sensitivity and specificity of any imaging 
modality for the identification of choledocholithiasis (Table 1). It is also a very sensitive 
technique for visualization of pancreatic lesions, pseudocysts, and elucidating pancreatic 
ductal anatomy. Like transabdominal ultrasound, EUS is somewhat operator dependent, 
and access to EUS may be limited in some centers. 
 
Imaging Modality Sensitivity (%) Specificity (%) PPV (%) NPV (%) 
U/S – Gallstones 67-87 93 100 75-80 
U/S – CBD Stones 20-50 83 67 39 
CT 40 92 89 48 
MRCP 80-100 83-98 89 71-100 
ERCP 90-100 92 95 85 
EUS 91-100 85-100 92-98 88-92 
PPV = positive predictive value, NPV = negative predictive value, U/S = ultrasound,  
CBD = common bile duct, CT = computed tomography, MRCP = magnetic resonance 
cholangiopancreatography, ERCP = endoscopic retrograde cholangiopancreatography,  
EUS = endoscopic ultrasound 
Table 1. Test characteristics of the common abdominal imaging modalities 
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5. Assessment of severity 
Determining whether a given case of acute pancreatitis is mild or severe has important 
management and prognostic implications. Those with severe disease (up to 20% of ABP) 
may require admission to a monitored setting as they have morbidity rates of 30-50% and 
mortality rates up to 10-30% despite ICU management.23 Several scoring systems exist, 
including Ranson’s score, which combines 11 clinical data criteria, 5 from the first 24 hours, 
and the remaining 6 at 48 hours (Table 2). Each criterion is assigned 1 point, with scores ≥3 
points representing severe pancreatitis, correlating with a 15% mortality rate, and scores 
more than 6 points carrying a mortality rate upwards of 50%. 
 
 Non-biliary Pancreatitis Biliary Pancreatitis 
On Admission 
 Age >55 >70 
 WBC (mm3) >16,000 >18,000 
 Blood glucose (mg/dl) >200 >220 
 LDH (U/L) >350 >400 
 AST (U/L) >250 >250 
48 Hours 
 Fall in hematocrit (%) >10 >10 
 Rise in BUN (mg/dl) >5 >2 
 Calcium (mg/dl) <8 <8 
 PaO2 (mmHg) <60 <60 
 Base deficit (mEq/L) >4 >5 
 Fluid sequestration (L) >6 >4 
WBC = white blood cell count, LDH = lactate dehydrogenase, AST = aspartate amino- 
transferase, BUN = blood urea nitrogen, PaO2 = arterial partial pressure of oxygen 
Table 2. Ranson’s Criteria of severity for non-biliary and biliary origin of pancreatitis 
A second scoring system validated for use in acute pancreatitis is the Acute Physiology and 
Chronic Health Evaluation (APACHE-II), calculated by adding 12 individual variable 
points, age points, and chronic health points. A score over 8 represents severe pancreatitis, 
and a score below 8 is unlikely to result in a fatal outcome. Although the APACHE-II score 
is cumbersome to calculate, its benefit over Ranson’s score is that it can be repeated over the 
course of illness, whereas Ranson’s score applies only to the initial 48 hours after 
presentation. Another commonly used scoring system is the CT severity index (CTSI), which 
combines CT grade with extent of necrosis to assign a score that reliably correlates with 
morbidity and mortality rates (Table 3). A score of 3 or above represents severe pancreatitis 
with scores 3-6 corresponding to a 35% morbidity and 6% mortality rate, and scores 7-10 
corresponding to morbidity and mortality rates of 92% and 17% respectively.24 
                                                 
23 Howard T. (2008) Management of gallstone pancreatitis, In: Current surgical therapy, 9th ed. Cameron J. 
pp. 477-480. Mosby Elsevier Inc., ISBN: 978-1-4160-3497-1, Philadelphia.  
24 Howard T. (2008) Management of gallstone pancreatitis, In: Current surgical therapy, 9th ed. Cameron J. 
pp. 477-480. Mosby Elsevier Inc., ISBN: 978-1-4160-3497-1, Philadelphia. 
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CT Grade Points Necrosis (%) Points Total CTSI score 
A 0   0 
B 1 0 0 1 
C 2 <30 2 4 
D 3 30-50 4 7 
E 4 >50 6 10 
Grade A = normal pancreas, B = pancreatic enlargement, C = inflammation of the pancreas and/or 
peripancreatic fat, D = single peripancreatic fluid collection, E = two or more peripancreatic fluid 
collections and/or retroperitoneal air.  
Table 3. CT Severity Index (CTSI).  
6. Management 
Initial management of biliary pancreatitis is mainly directed at supportive care, limiting 
complications, and prevention of infection in the case of pancreatic necrosis. All patient are 
treated with bowel rest, fluid resuscitation, as well as appropriate analgesia and anti-
emetics. Attempts should be made to re-institute oral nutrition, preferably post-pyloric with 
a jejunal nasoenteric feeding tube, however if oral nutrition is to be withheld for more than 
5-7 days on the basis of ongoing fever, tachycardia, nausea, vomiting, severe abdominal 
pain, or leukocytosis, nutritional support with parenteral nutrition should be considered. 
Severe pancreatitis or development of systemic complications should be managed in a 
monitored setting such as the intensive care unit. There may be a role for urgent ERCP in 
select situations with patients who present jaundiced or have evidence of biliary sepsis.  
Unique to a biliary origin of pancreatitis is the requirement for definitive removal of the 
etiologic trigger with cholecystectomy (or ERCP/ES). In severe cases of pancreatitis, 
cholecystectomy should be delayed at least 3 weeks to minimize the risk of infecting the 
pancreatic necrosis at the time of surgery. Also, in patients with evidence of large 
peripancreatic fluid collections, cholecystectomy may be delayed up to 6 weeks to allow for 
the maturation of a pseudocyst that can be drained at the time of surgery. In a study by 
Kelly and Wagner, 165 patients presenting with ABP were randomized to early surgery 
within 48 hours after admission or delayed surgery after 48 hours. The early surgery group 
was associated with higher rates of morbidity and mortality when compared to the late 
group with 83 versus 48% for morbidity and 18 versus 12% for mortality.25 
In the case of mild biliary pancreatitis, practice guidelines from several international 
societies have recommended early cholecystectomy, but the definition of early has not been 
clearly defined and varies between the different guidelines. The International Association of 
Pancreatology has recommended cholecystectomy should be ideally performed prior to 
discharge from the initial hospitalization for pancreatitis.26 The UK Working Party on Acute 
Pancreatitis have recommended that cholecystectomy not be delayed more than two weeks 
                                                 
25 Kelly T, Wagner D. Gallstone pancreatitis: a prospective randomized trial of the timing of surgery. 
Surgery 1988;104:600-605. 
26 Uhl W, Warshaw A, Imrie C, et al. IAP Guidelines for the surgical management of acute pancreatitis. 
Pancreatology 2002;2:565-573. 
www.intechopen.com
 
Pancreatitis – Treatment and Complications 
 
26
after discharge from the index admission,27 whereas the American Gastroenterological 
Association guidelines allow for 2-4 weeks after discharge.28 Guidelines from the American 
College of Gastroenterology state early cholecystectomy should be performed, but do not 
define a particular target.29 Perhaps the reason for the lack of consensus is due to that 
evidence for these recommendations is largely based on single-center observational studies 
and not large randomized clinical trial data. Studies done to date have demonstrated a risk 
of recurrent biliary pancreatitis from 25 to 63% when cholecystectomy was delayed until 
after discharge from the index hospitalization.30,31,32  
In a retrospective observational study of 281 patients with ABP, Ito et al. demonstrated 
gallstone-related complications in 33% of patients who did not have index cholecystectomy, 
with recurrent ABP found in 13.4% of patients (versus no recurrences in the index 
cholecystectomy group). Of note, almost one third of recurrences occurred within 2 weeks 
after discharge, and half of recurrences occurred within 4 weeks.33 They also looked at 
ERCP with ES as definitive treatment in 42 out of the 119 patients who did not have index 
cholecystectomy. A significant reduction in recurrence of ABP was noted in the ES group 
compared to no intervention group with rates of 4.8 versus 18.2% respectively. However, 
rates of biliary complications such as acute cholecystitis, jaundice, and cholangitis did occur 
with greater frequency in the ES group versus no intervention group. This trend of 
decreased recurrence of ABP but increased biliary complications has been replicated in 
several other studies, and as such, ERCP with ES should not be used in place of 
cholecystectomy for definitive treatment except in the case of patients who are deemed to be 
poor surgical candidates.34 
Other than reduced recurrence rates, several benefits have been identified with early 
cholecystectomy during index hospitalization. A recent randomized prospective study has 
suggested that early cholecystectomy may actually reduce length of index hospitalization. 
This study looked at 50 patients who were admitted with mild ABP, with half randomized 
to the early group where cholecystectomy was performed within 48 hours of admission 
regardless of whether abdominal pain had subsided or laboratory values had normalized. 
They found that hospital length of stay was shorter for the early cholecystectomy group 
with an average of 3.5 days as compared to the control group with an average stay of 5.8 
                                                 
27 UK Working Party on Acute Pancreatitis. UK guidelines for the management of acute pancreatitis. 
Gut 2005;54(Suppl 3):iii1-9. 
28 Forsmark CE, Baillie J. AGA Institute technical review on acute pancreatitis. Gastroenterology 
2007;132(5):2022-44. 
29 Banks PA, Freeman ML. Practice guidelines in acute pancreatitis. American Journal of Gastroenterology 
2006;101(10):2379-400. 
30 Uhl W, Muller CA, Krahenbuhl L, Schmid SW, Scholzel S, Buchler MW. Acute gallstone pancreatitis: 
timing of laparoscopic cholecystectomy in mild and severe disease. Surg Endo 1999;13:1070-1076. 
31 Ranson JH. The role of surgery in the management of acute pancreatitis. Ann Surg 1990;211:382-393. 
32 Ranson JH. The timing of biliary surgery in acute pancreatitis. Ann Surg 1979;189:654-663. 
33 Ito K, Ito H, Whang E. Timing of cholecystectomy for biliary pancreatitis: do the data  
support current guidelines? Journal of Gastrointestinal Surgery 2008;12:2164-2170. 
34 Kimura Y, Arata S, Takada T, et al. Gallstone-induced acute pancreatitis. Journal of Hepatobiliary 
Pancreatic Sciences 2010;17:60-69. 
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days (p=0.0016).35 Of note, they did not find any statistically significant differences in the 
need to convert to open cholecystectomy or peri-operative complications between the two 
groups. Previous observational studies have also shown similar results. One of the largest 
series is that of 281 patients, of which 162 underwent cholecystectomy during index 
admission, where length of stay was 5 days for the early group compared to 7 days for the 
post-discharge cholecystectomy group. This difference was exaggerated further by the fact 
that 33% of the post-discharge cholecystectomy group required at least one other pre-
cholecystectomy admission for gallstone-related events, resulting in an average of 3 
additional days in hospital.36 
Despite the decrease in biliary complications, reduced length of stay, and reduced 
readmissions, several studies have shown that most jurisdictions are still not following 
guidelines for early cholecystectomy. One retrospective study looked at 100 consecutive 
patients admitted with ABP and found only 40 had surgery within the index admission, 
with another 38 who were discharged for interval cholecystectomy. Two of the 38 were re-
admitted while waiting for surgery with biliary complications.37 Nguyen et al. explored 
whether lack of resources was a contributing factor to low compliance with guidelines, and 
they demonstrated that the rate of cholecystectomy during index admission increased at 
centers with the highest annual volume of cholecystectomies, decreased at centers with the 
highest volumes of acute pancreatitis, and decreased in centers with the highest volumes of 
ERCP.38 These results confirm the hypothesis that resource intensification may be necessary 
to more consistently meet international guidelines. 
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